Insider Transactions Screener
Search for and identify insider purchases or sales of company shares. The screener offers additional information and analysis on the transactions and allows users to set up alerts and receive notifications when new transactions occur.
Ticker | Insider | Transaction Type | Ownership Type | Shares Traded | Value / Price | Filing Date |
---|---|---|---|---|---|---|
PEP
|
Robert C Pohlad
Director |
BUY
Grant, award, or other acquisition
|
Direct | 1,860 Added 0.82% |
-
|
Mar 23
2015 |
PEP
|
Richard W Fisher
Director |
BUY
Grant, award, or other acquisition
|
Direct | 1,860 Added 50.0% |
-
|
Mar 23
2015 |
PEP
|
William R Johnson
Director |
BUY
Grant, award, or other acquisition
|
Direct | 1,860 Added 31.95% |
-
|
Mar 23
2015 |
SNPS
|
Brian M Beattie
EVP, Business Ops. & CAO |
SELL
Open market or private sale
|
Direct | 2,400 Reduced 7.21% |
$112,968
$47.07 p/Share
|
Mar 23
2015 |
SNPS
|
Brian M Beattie
EVP, Business Ops. & CAO |
BUY
Exercise of conversion of derivative security
|
Direct | 1,200 Added 3.48% |
$31,872
$26.56 p/Share
|
Mar 23
2015 |
ARES
|
Michael R Mc Ferran
COO & CFO |
BUY
Grant, award, or other acquisition
|
Direct | 27,248 Added 50.0% |
-
|
Mar 23
2015 |
APOG
|
Joseph F. Puishys
Chief Executive Officer & Pres |
BUY
Exercise of conversion of derivative security
|
Direct | 34,871 Added 11.0% |
$290,824
$8.34 p/Share
|
Mar 23
2015 |
APOG
|
Joseph F. Puishys
Chief Executive Officer & Pres |
SELL
Open market or private sale
|
Direct | 34,871 Reduced 12.36% |
$1,545,134
$44.31 p/Share
|
Mar 23
2015 |
CVS
|
Troyen A Brennan
EVP and Chief Medical Officer |
SELL
Open market or private sale
|
Direct | 33,274 Reduced 37.66% |
$3,491,774
$104.94 p/Share
|
Mar 23
2015 |
CVS
|
Troyen A Brennan
EVP and Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct | 33,274 Added 27.36% |
$1,499,659
$45.07 p/Share
|
Mar 23
2015 |
ADI
|
Thomas Wessel
SVP, WW Sales & Mkting |
SELL
Open market or private sale
|
Direct | 4,310 Reduced 100.0% |
$260,927
$60.54 p/Share
|
Mar 23
2015 |
NP
|
John P O'Donnell
President and CEO |
SELL
Open market or private sale
|
Direct | 8,578 Reduced 100.0% |
$538,270
$62.75 p/Share
|
Mar 23
2015 |
NP
|
John P O'Donnell
President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct | 2,733 Added 78.74% |
$89,396
$32.71 p/Share
|
Mar 23
2015 |
ADI
|
David Zinsner
SVP, Finance & CFO |
SELL
Other acquisition or disposition
|
Direct | 14,752 Reduced 48.19% |
-
|
Mar 23
2015 |
ADI
|
Ray Stata
Director |
SELL
Open market or private sale
|
Indirect | 25,000 Reduced 2.31% |
$1,512,500
$60.5 p/Share
|
Mar 23
2015 |
APOG
|
Sara L Hays
Director |
SELL
Bona fide gift
|
Direct | 225 Reduced 0.97% |
-
|
Mar 22
2015 |
NVDA
|
Ajay K Puri
EVP, Worldwide Field Ops |
BUY
Open market or private purchase
|
Direct | 94 Added 0.02% |
$2,193
$23.33 p/Share
|
Mar 20
2015 |
NP
|
John P O'Donnell
President and CEO |
SELL
Open market or private sale
|
Direct | 1,455 Reduced 100.0% |
$91,301
$62.75 p/Share
|
Mar 20
2015 |
ADI
|
David Zinsner
SVP, Finance & CFO |
SELL
Open market or private sale
|
Direct | 7,500 Reduced 19.68% |
$452,025
$60.27 p/Share
|
Mar 20
2015 |
ADI
|
Ray Stata
Director |
SELL
Open market or private sale
|
Indirect | 25,000 Reduced 2.25% |
$1,523,750
$60.95 p/Share
|
Mar 20
2015 |
ARE
|
James H Richardson
Director |
SELL
Open market or private sale
|
Direct | 5,000 Reduced 5.19% |
$502,350
$100.47 p/Share
|
Mar 20
2015 |
ARE
|
Thomas J Andrews
Co-President |
SELL
Open market or private sale
|
Direct | 9,000 Reduced 9.01% |
$899,640
$99.96 p/Share
|
Mar 20
2015 |
CVS
|
C David Brown Ii
Director |
SELL
Open market or private sale
|
Direct | 25,000 Reduced 17.7% |
$2,607,500
$104.3 p/Share
|
Mar 20
2015 |
NKE
|
Donald W Blair
EVP: CFO |
SELL
Open market or private sale
|
Direct | 50,000 Reduced 19.42% |
$5,134,000
$102.68 p/Share
|
Mar 20
2015 |
NKE
|
Donald W Blair
EVP: CFO |
BUY
Exercise of conversion of derivative security
|
Direct | 50,000 Added 16.26% |
$1,311,000
$26.22 p/Share
|
Mar 20
2015 |
PRTA
|
Tara Nickerson
Chief Business Officer |
BUY
Exercise of conversion of derivative security
|
Direct | 13,000 Added 46.43% |
$83,330
$6.41 p/Share
|
Mar 20
2015 |
PRTA
|
Tara Nickerson
Chief Business Officer |
SELL
Open market or private sale
|
Direct | 13,000 Reduced 86.67% |
$519,870
$39.99 p/Share
|
Mar 20
2015 |
SPOK
|
Colin Balmforth
President of USA Mobility Wire |
SELL
Open market or private sale
|
Direct | 6,000 Reduced 13.36% |
$116,580
$19.43 p/Share
|
Mar 20
2015 |
ARE
|
Joel S Marcus
Executive Chairman |
SELL
Open market or private sale
|
Direct | 2,500 Reduced 0.45% |
$253,425
$101.37 p/Share
|
Mar 20
2015 |
ACU
|
Walter C Johnsen
Chairman and CEO |
SELL
Open market or private sale
|
Direct | 1,219 Reduced 0.38% |
$22,247
$18.25 p/Share
|
Mar 20
2015 |
ACU
|
Walter C Johnsen
Chairman and CEO |
BUY
Exercise of conversion of derivative security
|
Direct | 1,219 Added 0.37% |
$19,077
$15.65 p/Share
|
Mar 20
2015 |
ADBE
|
James E Daley
Director |
SELL
Open market or private sale
|
Direct | 5,000 Reduced 19.47% |
$385,000
$77.0 p/Share
|
Mar 19
2015 |
ADBE
|
James E Daley
Director |
BUY
Exercise of conversion of derivative security
|
Direct | 5,000 Added 16.3% |
$213,050
$42.61 p/Share
|
Mar 19
2015 |
ADBE
|
Mark Garrett
EVP, CFO & Asst. Secretary |
SELL
Open market or private sale
|
Direct | 8,615 Reduced 100.0% |
$656,808
$76.24 p/Share
|
Mar 19
2015 |
NVDA
|
Ajay K Puri
EVP, Worldwide Field Ops |
SELL
Open market or private sale
|
Direct | 45,000 Reduced 8.01% |
$1,046,250
$23.25 p/Share
|
Mar 19
2015 |
NVDA
|
Ajay K Puri
EVP, Worldwide Field Ops |
BUY
Exercise of conversion of derivative security
|
Direct | 45,000 Added 7.42% |
$717,300
$15.94 p/Share
|
Mar 19
2015 |
FSLR
|
James Alton Hughes
Director |
SELL
Payment of exercise price or tax liability
|
Direct | 4,830 Reduced 17.94% |
$291,249
$60.3 p/Share
|
Mar 19
2015 |
FSLR
|
James Alton Hughes
Director |
BUY
Exercise of conversion of derivative security
|
Direct | 10,464 Added 27.99% |
-
|
Mar 19
2015 |
FSLR
|
James Alton Hughes
Director |
SELL
Other acquisition or disposition
|
Direct | 2,817 Reduced 12.75% |
-
|
Mar 19
2015 |
DJCO
|
John Patrick Et Al Guerin
Director |
SELL
Open market or private sale
|
Indirect | 1,437 Reduced 0.88% |
$278,778
$194.0 p/Share
|
Mar 19
2015 |
TMUS
|
J Braxton Carter Ii
EVP & CFO |
SELL
Open market or private sale
|
Direct | 1,000 Reduced 0.44% |
$33,470
$33.47 p/Share
|
Mar 19
2015 |
CSCO
|
Pankaj Patel
EVP, Chief Development Officer |
SELL
Open market or private sale
|
Direct | 12,052 Reduced 2.01% |
$341,433
$28.33 p/Share
|
Mar 19
2015 |
SPOK
|
Colin Balmforth
President of USA Mobility Wire |
SELL
Open market or private sale
|
Direct | 2,000 Reduced 4.26% |
$38,240
$19.12 p/Share
|
Mar 19
2015 |
ELDN
|
Novartis Bioventures LTD
> 10% Shareholder |
SELL
Open market or private sale
|
Direct | 46,141 Reduced 0.99% |
$669,044
$14.5 p/Share
|
Mar 19
2015 |
ADI
|
Ray Stata
Director |
SELL
Open market or private sale
|
Direct | 50,000 Reduced 16.34% |
$3,000,500
$60.01 p/Share
|
Mar 19
2015 |
ADI
|
John C Hodgson
Director |
SELL
Open market or private sale
|
Direct | 1,600 Reduced 14.57% |
$93,936
$58.71 p/Share
|
Mar 18
2015 |
LOW
|
Maureen K Ausura
EVP Human Resources |
SELL
Bona fide gift
|
Direct | 40 Reduced 0.05% |
-
|
Mar 18
2015 |
MDT
|
Hoedt Rob Ten
EVP and Pres. Global Regions |
SELL
Open market or private sale
|
Direct | 7,619 Reduced 25.4% |
$589,787
$77.41 p/Share
|
Mar 18
2015 |
ELDN
|
Novartis Bioventures LTD
> 10% Shareholder |
SELL
Open market or private sale
|
Direct | 3,000 Reduced 0.06% |
$43,500
$14.5 p/Share
|
Mar 18
2015 |
NVDA
|
Michael Byron
Principal Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct | 8,102 Reduced 5.17% |
$185,293
$22.87 p/Share
|
Mar 18
2015 |